关于印度成年人免疫接种的伤寒疫苗的IAPSM的立场文件
Kapil Goel1, Madhur Verma2, Nikita Sharma3
1Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
概括
建议在印度的45岁以下的成年人接种伤寒联合疫苗 (TCV),以对抗这种疾病. 印度预防和社会医学协会 (IAPSM) 倡导将它们纳入免疫接种计划.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- 由沙门氏菌Typhi引起的伤寒热是印度的一个重大公共卫生问题,城市贫民窟的卫生条件不佳加剧了这一问题.
- 伤寒的经济影响很大,影响家庭和国家资源,强调需要采取有效的控制措施.
- 虽然儿童接种疫苗的证据很强,但成年人接种伤寒疫苗仍然不那么成熟.
研究的目的:
- 评估印度广泛的伤寒疫苗接种计划的必要性,并推战略.
- 评估新一代伤寒结合疫苗 (TCVs) 对所有年龄组 (包括成年人) 的作用.
- 强调营销后监测对疫苗安全性和有效性的重要性.
主要方法:
- 审查现有证据的伤寒负担和疫苗有效性在印度和LMICs.
- 印度预防和社会医学协会 (IAPSM) 关于免疫策略的建议.
- 考虑新一代伤寒联合疫苗 (TCVs) 的广泛适用性.
主要成果:
- IAPSM承认需要一个全面的伤寒免疫计划,优先考虑弱势群体.
- 推TCV是因为它们的长期和优越的免疫效益,适用于所有年龄段.
- 建议在长达45岁的成年人中常规使用Typbar-TCVTM,并进行营销后监测.
结论:
- 广泛的伤寒免疫,特别是TCV,是印度有效的疾病控制所必需的.
- 建议在45岁以下的成年人接种TCV疫苗,需要持续监测安全性和有效性.
- 针对更广泛的沙门氏菌感染的疫苗的进一步开发对于加强伤寒控制工作至关重要.
更多相关视频
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
16.8K
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
3.3K
相关概念视频
01:51Vaccinations
43.1K
Overview
43.1K
01:30Acute Pharyngitis
320
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
320